Gainesville, FL, United States of America

Mike King

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike King. Retrieved from https://idiyas.com/inventor/mike-king-jf7tlt03

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mike King - Innovator in Human Disease Modeling

Introduction

Mike King is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of medical research, particularly in the area of human disease modeling. His innovative work focuses on utilizing somatic gene transfer to better understand and analyze neurodegenerative diseases.

Latest Patents

Mike King holds a patent for his invention titled "Human disease modeling using somatic gene transfer." This invention provides a system for modeling neurodegenerative and other diseases through somatic gene transfer. In addition, it includes methods for multiple gene transfer, disease analysis, and drug testing. He has 1 patent to his name.

Career Highlights

Mike King is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on understanding complex diseases and developing new therapeutic strategies.

Collaborations

Throughout his career, Mike has collaborated with notable colleagues, including Ronald Klein and Edwin M Meyer. These partnerships have contributed to the advancement of research in the field of gene transfer and disease modeling.

Conclusion

Mike King's innovative contributions to human disease modeling through somatic gene transfer highlight his commitment to advancing medical research. His work not only enhances our understanding of neurodegenerative diseases but also paves the way for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…